Canada’s health regulator approves Pfizer’s Covid-19 vaccine

The Pfizer/BioNTech Covid-19 vaccine has already been approved in the UK (Victoria Jones/PA)
The Pfizer/BioNTech Covid-19 vaccine has already been approved in the UK (Victoria Jones/PA)

Canada’s health regulator has approved Pfizer’s Covid-19 vaccine.

Health Canada posted on its website that the vaccine made by US drug manufacturer Pfizer and Germany’s BioNTech has been authorised.

A statement said: “Canadians can feel confident that the review process was rigorous and that we have strong monitoring systems in place. Health Canada and the Public Health Agency of Canada will closely monitor the safety of the vaccine once it is on the market and will not hesitate to take action if any safety concerns are identified.”

Canada is set to receive up to 249,000 doses this month and 4 million doses of the vaccine by March.

The UK began vaccinations with the shot made by Pfizer and BioNTech on Tuesday.

US regulators have also released their first scientific evaluation of Pfizer’s Covid-19 vaccine and confirmed it offers strong protection. Vaccines are emerging from an all-out worldwide race and are reaching the market less than a year after the virus was identified – a remarkable scientific achievement that shaved years off the usual process.

The encouraging developments come as coronavirus continues surging across much of the world. The virus has claimed more than 1.5 million lives.

US Food and Drug Administration scientists are meeting on Thursday, when the agency’s independent advisers will debate if the evidence is strong enough to recommend vaccinating millions of Americans.

Sean Marett, BioNTech’s chief business and chief commercial officer, said: “It is encouraging to see that our mRNA vaccine is now authorised in Canada. Following UK and Bahrain, it is the third country to approve use of our vaccine within a week.”

US FDA scientists reanalysed data and found the Pfizer vaccine appears safe and more than 90% effective across patients of different ages, races and underlying health conditions.

(PA Graphics)

Health Canada said the vaccine is for use in people 16 years of age or older, but noted Pfizer-BioNTech are running further clinical trials on children of all age groups and that could change.

Canada recently amended the contract with Pfizer so that it would deliver up to 249,000 doses this month. That will mean about 124,500 of the highest risk Canadians will get vaccinated at first as two doses are required per person a few weeks apart.

Pfizer and BioNTech said it will supply a minimum of 20 million doses to Canada through 2021 and as many as 76 million.

Canada has contracts with six other vaccine makers as well.

The Canadian government has said 14 distribution centres will be located in large cities initially. There will be at least one in each province and two each in Canada’s four largest provinces.

“This is phenomenal news for all Canadians as we take the next step toward ending this pandemic. As soon as vaccines arrive on Ontario soil, we will be ready to deliver and administer them,” Ontario premier Doug Ford said in a tweet.

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited